Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at a post on X:
“A great summary by Niklas Klümper and Viktor Grüenwald and team about the role of Mismatch Repair (MMR)/Microsatellite lnstability (MSI) and tumor mutational burden as a predictive marker for response to immunotherapy in patients with metastatic castration resistant prostate cancer.”
Additional information
Source: Emre Yekedüz/X